NEOG: יחס שווי פעילות לרווח לפני ריבית, מסים ופחת Neogen Corporation

The investment appeal of Neogen Corporation (NEOG) is based on global sales of diagnostic tests for the veterinary and food industries. The GURU.Markets service provides the current EV/EBITDA multiple for the business, where 26.61 is recorded as the baseline value. The asset's stability is confirmed by the low cyclicality of quality control and the company's impeccable reputation as the primary guarantor of global food security.

For Neogen Corporation (NEOG), which invests in the robotization of laboratory food safety controls, this indicator determines the business value including net debt relative to operating profit. By analyzing the EV/EBITDA valuation trend, an investor compares the total cost of acquiring the asset with its ability to generate cash flow before taxes, depreciation, and amortization, thereby identifying whether the shares are overbought or undervalued.